Epithelioid sarcoma: two variants of the same entity

Authors

  • Luca Garin Troyer General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina
  • Valeria Cecilia Orsi J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Ana Campastri J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Iris Barrio J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • César Chiappe J.M. Ramos Mejía Acute Hospital General, Autonomous City of Buenos Aires, Argentina
  • Guadalupe Ailín García General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina
  • Paula Bourren Dr. Juan A. Fernández General Acute Hospital, Autonomous City of Buenos Aires, Argentina
  • Cecilia Eleonora Ventrice General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina
  • Ana Clara Acosta J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Keywords:

sarcomas, epithelioid sarcoma, INI1, SMARCB1

Abstract

Sarcomas are malignant neoplasms that originate from mesenchymal tissue. Epithelioid sarcoma is a rare variant of soft tissue sarcoma, representing approximately 1% of them. There are two variants: a distal type and a proximal one, with a high recurrence and metastasis rate.

Two cases of male patients with epithelioid sarcoma are presented, one with the distal variant and the other with the proximal variant.

Author Biographies

Luca Garin Troyer, General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina

Dermatologist, Department of Dermatology and Pathology

Valeria Cecilia Orsi, J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Second Year Resident Physician, Dermatology and Pathology Service

Ana Campastri, J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist, Department of Dermatology and Pathology

Iris Barrio, J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist. Staff Physician, Dermatology and Pathology Department

César Chiappe, J.M. Ramos Mejía Acute Hospital General, Autonomous City of Buenos Aires, Argentina

Pathologist. Staff Physician, Dermatology and Pathology Service

Guadalupe Ailín García, General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina

Medical Pathologist, Department of Dermatology and Pathology

Paula Bourren, Dr. Juan A. Fernández General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist. Head of Service, Dermatology and Pathology Service

Cecilia Eleonora Ventrice, General Acute Hospital Dr. Juan A. Fernández, Autonomous City of Buenos Aires, Argentina

Dermatologist and Pathologist. Staff Physician, Department of Dermatology and Pathology

Ana Clara Acosta, J.M. Ramos Mejía General Acute Hospital, Autonomous City of Buenos Aires, Argentina

Dermatologist. Staff Physician, Dermatology and Pathology Department

References

I. Enzinger FM. Epithelioid sarcoma: a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.

II. Mestroni M, Marini M, Allevato M. Sarcoma epitelioide. En: Marini M, Casas J, Saponaro A et ál. Tumores cutáneos malignos infrecuentes: sarcomas. Buenos Aires: Alfaomega; 2012:145-155.

III. Chase DR, Enzinger FM. Epithelioid sarcoma: diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 1985;9:241-263.

IV. Manzanares-Campillo MC, Muñoz-Atienza V, Sánchez-García S, Gil-Rendo A, et ál. Sarcoma epitelioide de tipo proximal en pubis. Presentación de un caso y revisión de la literatura. Cir Cir. 2011;79:560-563.

V. Noujaim J, Thway K, Bajwa Z, Bajwa A, et ál. Epithelioid sarcoma: opportunities for biology-driven targeted therapy. Front Oncol 2015;5:186.

VI. Thway K, Jones RL, Noujaim J, Fisher C. Epithelioid sarcoma: diagnostic features and genetics. Adv Anat Pathol. 2016;23:41-49.

VII. Mannan AA, Rifaat AA, Kahvic M, Kapila K, et ál. Proximal-type epithelioid sarcoma in the groin presenting as a diagnostic dilemma. Pathol Oncol Res. 2010;16:181-188.

VIII. Baratti D, Pennacchioli E, Casali PG, Bertulli R, et ál. Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2007;14:3542-3551.

IX. Bloustein PA, Silverberg SG, Waddell WR. Epithelioid sarcoma: case report with ultrastructural review, histogenetic discussion, and chemotherapeutic data. Cancer. 1976;38:2390-2400.

X. Puissegur-Lupo ML, Perret WJ, Millikan LE. Epithelioid sarcoma. Report of a case. Arch Dermatol. 1985;121:394-395.

XI. Evans HL, Baer SC. Epithelioid sarcoma: a clinicopathologic and prognostic study of 26 cases. Semin Diagn Pathol. 1993;10:286-291.

XII. Spillane AJ, Thomas JM, Fisher C. Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma. Ann Surg Oncol. 2000;7:218-225.

XIII. Prat J, Woodruff JM, Marcove RC. Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis. Cancer. 1978;41:1472-1487.

XIV. Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, et ál. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.

XV. Castillo R, Bosch R, Sáenz S, Gallego E, et ál. Sarcoma epitelioide. Un tumor de difícil diagnóstico. Actas Dermosifiliogr. 2004;95:183-186.

XVI. Barbaro V, Minaudo C, Rey Campero M, Marini M, et ál. Sarcoma epitelioide. Dermatol Argent. 2014;20:113-118.

XVII. Livi L, Shah N, Paiar F, Fisher C, et ál. Treatment of epithelioid sarcoma at Royal Marsden Hospital. Sarcoma. 2003;7:149-152.

XVIII. López Pousa A. Tratamiento de los sarcomas de partes blandas. Servicio de Oncología Médica. Hospital de la Santa Creu i Sant Pau. IX Congreso SEOM. Barcelona;2016:145-153.

XIX. Gounder M, Schöffski P, Jones RL, Agulnik M, et ál. Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020;21:1423-1432.

Published

2022-09-01

Issue

Section

Original Articles